Skip to main content
Log in

Nutrition and cervical neoplasia

Cancer Causes & Control Aims and scope Submit manuscript

Epidemiologic evidence on the relation between nutrition and cervical cancer is reviewed. Cervical cancer is the leading cancer among women in many developing countries, and remains a major public health problem worldwide. This review of nutritional research on cervical neoplasia encompasses the range of epithelial abnormalities from early preneoplastic lesions to invasive cancer. Identified risk factors for cervical neoplasia suggest a multifactorial etiology with several cancer-associated human papillomaviruses (HPV) as the central cause. Studies of nutritional predictors of cervical neoplasia to date, however, have been limited by inadequate HPV measures, which compromise the interpretations of findings. Current research using accurate measures of HPV will be most revealing. Nonetheless, agreement in findings from previous studies suggest a role for nutritional factors in some or all stages of cervical neoplasia. Low vitamin C and carotenoid status are associated fairly consistently with both cervical cancer and precursors, whereas results for vitamin E status are less consistent. The effect of folate status may be restricted to early preneoplastic cervical lesions and not to more advanced disease. Current research is addressing nutritional influences on HPV infection and persistence and on progression of cervical disease. Limitations and recommendations for future research directions are discussed in light of methodologic issues related to nutritional and HPV research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Parkin DM, Pisani P, Ferlay J. Estimates of the world-wide frequency of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594–606.

    Google Scholar 

  2. Doll R, Peto R. The Causes of Cancer. Quantitative Estimates of Avoidable Risks of Cancer in the United States Today. New York, NY (USA): Oxford University press, 1981.

    Google Scholar 

  3. Schiffman MH, Brinton LA, Fraumeni JF Jr, Devesa SS. Cervical cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology. New York, NY (USA): Oxford University Press, in press.

  4. zur Hausen H. Human Pathogenic Papillomaviruses. Heidelberg, Germany: Springer Verlag, 1994.

    Google Scholar 

  5. Franco EL. The sexually transmitted disease model for cervical cancer: incoherent epidemiologic findings and the role of misclassification of human papillomavirus infection. Epidemiology 1991; 2: 98–106.

    Google Scholar 

  6. Schiffman MH. Validation of HPV hybridization assays: correlation of filter in situ, dot blot and PCR with Southern blot. In: Muñoz N, Boxch FX, Shah KV, Meheus A, eds. The Epidemiology of Human Papillomavirus and Cervical Cancer. Lyon, France: IARC, 1992 IARC Sci. Pub. No. 119: 169–79.

    Google Scholar 

  7. Wright TC, Kurman RJ. A critical review of the morphologic classification systems of preinvasive lesions of the cervix: the scientifie basis for shifting the paradigm. Papillomavirus Report 1994; 5: 175–82.

    Google Scholar 

  8. Whitehead N, Reyner F, Lindenbaum J. Megaloblastic changes in the cervical epithelium: association with oral contraceptive therapy and reversal with folic acid. JAMA 1973; 226: 1421–4.

    Google Scholar 

  9. King JC, Bronstein MN, Ritch WL, et al. Nutrient utilization during pregnancy. World Rev Nutr Diet 1987; 52: 71–142.

    Google Scholar 

  10. Bosch FX, Muñoz N, de Sanjose S, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992; 52: 750–8.

    Google Scholar 

  11. Cuzick J, Terry G, Ho L, et al. Human papillomvirus type 16 DNA in cervical smears as a predictor of high-grade cervical intraepithelial neoplasia. Lancet 1992; 339: 959–69.

    Google Scholar 

  12. Muñoz N, Bosch FX, de Sanjose S, et al. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarker Prev 1993; 2: 423–31.

    Google Scholar 

  13. Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJLM, Walboomers JMM. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 1994; 69: 114–9.

    Google Scholar 

  14. Hildesheim A, Schiffman MH, Gravitt P, et. al. Persistence of typespecific human papillomavirus infection among cytologically normal women in Portland, Oregon. J Infect Dis 1994; 169: 235–240.

    Google Scholar 

  15. Richart RM, Barron BA. A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol 1969; 105: 386–93.

    Google Scholar 

  16. Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. JNCI 1968; 40: 43–68.

    Google Scholar 

  17. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975; 15: 617–31.

    Google Scholar 

  18. Kolonel LN, Hankin JH, Lee J, Chu SY, Nomura AMY, Hinds MW. Nutrient intakes in relation to cancer incidence in Hawaii. Br J Cancer 1981; 44: 332–9.

    Google Scholar 

  19. Marshall JR, Graham S, Byers T, Swanson M, Brasure J. Diet and smoking in the epidemiology of cancer of the cervix. JNCI 1983; 70: 847–51.

    Google Scholar 

  20. Brock KE, Berry G, Mock PA, MacLennan R, Truswell AS, Brinton LA. Nutrients in diet and plasma and risk of in situ cervical cancer. JNCI 1988; 80: 580–5.

    Google Scholar 

  21. La Vecchia C, Decarli A, Fasoli M, et al. Dietary vitamin A and the risk of intraepithelial and invasive cervical neoplasia. Gynecol Oncol 1988; 30: 187–95.

    Google Scholar 

  22. Verreault R, Chu J, Mandelson M, Shy K. A case-control study of diet and invasive cervical cancer. Int J Cancer 1989; 43: 1050–4.

    Google Scholar 

  23. Ziegler RG, Brinton LA, Hamman RF, et al. Diet and the risk of invasive cervical cancer among white women in the United States. Am J Epidemiol 1990; 132: 432–45.

    Google Scholar 

  24. Slattery ML, Abbott TM, Overall JC, et al. Dietary vitamins A, C, and E and selenium as risk factors for cervical cancer. Epidemiology 1990; 1: 8–15.

    Google Scholar 

  25. Herrero R, Potischman N, Brinton LA, et al. A case-control study of nutrient status and invasive cervical cancer: I. Dietary indicators. Am J Epidemiol 1991; 134: 1335–46.

    Google Scholar 

  26. de Vet HCW, Knipschild PG, Grol MEC, Schouten HJA, Sturmans F. The role of beta-carotene and other dietary factors in the aetiology of cervical dysplasia: results of a case-control study. Int J Epidemiol 1991; 20: 603–10.

    Google Scholar 

  27. Ziegler RG, Jones CJ, Brinton LA,et. al. Diet and the risk of in situ cervical cancer among white women in the United States. Cancer Causes Control 1991; 2: 17–29.

    Google Scholar 

  28. Lambert B, Brisson G, Bielmann P. Plasma vitamin A and precancerous lesions of cervix uteri: A preliminary report. Gynecol Oncol 1981; 11: 136–9.

    Google Scholar 

  29. Harris RWC, Forman D, Doll R, Vessey MP, Wald NJ. Cancer of the cervix uteri and vitamin A. Br J Cancer 1986; 53: 653–9.

    Google Scholar 

  30. Palan PR, Romney SL, Mikhail M, Basu J, Vermund SH. Decreased plasma beta-carotene levels in women with uterine cervical dysplasias and cancer. JNCI 1988; 80: 454–5.

    Google Scholar 

  31. Palan PR, Mikhail MS, Basu J, Romney SL. Plasma levels of antioxidant beta-carotene and alpha-tocopherol in uterine cervix dysplasias and cancer. Nutr Cancer 1991; 15: 13–20.

    Google Scholar 

  32. Cuzick J, De Stavola BL, Russell MJ, Thomas BS. Vitamin A, vitamin E and the risk of cervical intraepithelial neoplasia. Br J Cancer 1990; 62: 651–2.

    Google Scholar 

  33. Potischman N, Herrero R, Brinton LA,et al. A case-control study of nutrient status and invasive cervical cancer: II. Serologic indicators. Am J Epidemiol 1991; 134: 1347–55.

    Google Scholar 

  34. Batieha AM, Armenian HK, Norkus EP, Morris JS, Spate VE, Comstock GW. Serum micronutrients and the subsequent risk of cervical cancer in a population-based nested case-control study. Cancer Epidemiol Biomarkers Prev 1993; 2: 335–9.

    Google Scholar 

  35. Meyskens FLJr, Surwit E, Moon TE,et al. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. JNCI 1994; 86: 539–43.

    Google Scholar 

  36. Linder MC. Nutrition and metabolism of vitamins. In: Linder MC, ed. Nutritional Biochemistry and Metabolism. New York, NY (USA): Elsevier Science Publishing Company, Inc. 1985: 69–131.

    Google Scholar 

  37. Palan PR, Mikhail MS, Basu J, Romney SL. β-carotene levels in exfoliated cervicovaginal epithelial cells in cervical intraepithelial neoplasia and cervical cancer. Am J Obstet Gynecol 1992; 167: 1899–903.

    Google Scholar 

  38. VanEenwyk J, Davis FG, Bowen PE. Dietary and serum carotenoids and cervical intraepithelial neoplasia. Int J Cancer 1991; 48: 34–8.

    Google Scholar 

  39. Potischman N, Hoover RN, Brinton LA, et al. The relations between cervical cancer and serological markers of nutritional status. Nutr Cancer 1994; 21: 193–201.

    Google Scholar 

  40. Smith AH, Waller KD. Serum beta-carotene in persons with cancer and their immediate families. Am J Epidemiol 1991; 133: 661–71.

    Google Scholar 

  41. de Vet HCW, Knipschild PG, Willebrand D, Schouten HJA, Sturmans F. The effect of beta-carotene on the regression and progression of cervical dysplasia: a clinical experiment. J Clin Epidemiol 1991; 44: 273–83.

    Google Scholar 

  42. Mackerras D, Baghurst P, Fairley C, Irwig L, Weisburg E, Simpson J. Beta-carotene and cervical dysplasia trials in Australia. Ann NY Acad Sci 1993; 691; 253–4.

    Google Scholar 

  43. Sankaranarayanan R, Wahrendorf J, Demaret E, eds. Directory of On-Going Research in Cancer Epidemiology. Lyon, France: International Agency for Research on Cancer, 1994; IARC Sci. Pub. No. 130: 408.

    Google Scholar 

  44. Wassertheil-Smoller S, Romney SL, Wylie-Rosett J, et al. Dietary vitamin C and uterine cervical dysplasia. Am J Epidemiol 1981; 114: 714–24.

    Google Scholar 

  45. Romney SL, Duttagupta C, Basu J, et al. Plasma vitamin C and uterine cervical dysplasia. Am J Obstet Gynecol 1985; 151: 976–80.

    Google Scholar 

  46. Basu J, Palan PR, Vermund SH, Goldberg GL, Burk RD, Romney SL. Plasma ascorbic acid and beta-carotene levels in women evaluated for HPV infection, smoking, and cervix dysplasia. Cancer Detect Prev 1991; 15: 165–70.

    Google Scholar 

  47. Van Eenwyk J, Davis FG, Colman N. Folate, vitamin C, and cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1992; 1: 119–24.

    Google Scholar 

  48. Knekt P. Serum vitamin E level and risk of female cancers. Int J Epidemiol 1988; 17: 281–6.

    Google Scholar 

  49. Stryker WS, Kaplan LA, Stein EA, Stampfer MJ, Sober A, Willett WC. The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol 1988; 127: 283–96.

    Google Scholar 

  50. Butterworth CEJr, Hatch KD, Gore H, Mueller J, Krumdiek CL. Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives. Am J Clin Nutr 1982; 35: 73–82.

    Google Scholar 

  51. Lambie DG, Johnson RH. Drugs and folate metabolism. Drugs 1985; 30: 145–55.

    Google Scholar 

  52. Butterworth CEJr, Hatch KD, Macaluso M, et al. Folate deficiency and cervical dysplasia. JAMA 1992; 267: 528–33.

    Google Scholar 

  53. Potischman N, Brinton LA, Laiming VA, et al. A case-control study of serum folate levels and invasive cervical cancer. Cancer Res 1991; 51: 4785–9.

    Google Scholar 

  54. Butterworth CEJr, Hatch KD, Soong S-J, et al. Oral folic acid supplementation for cervical dysplasia: a clinical intervention trial. Am J Obstet Gynecol 1992; 166: 803–9.

    Google Scholar 

  55. Childers JM, Chu J, Voight LF, et al. Chemoprevention of cervical cancer with folic acid: A phase III Southwest Oncology Group Intergroup Study. Cancer Epidemiol Biomarkers Prev 1995; 4: 155–9.

    Google Scholar 

  56. Harper JM, Levine AJ, Rosenthal DL, et al. Erythrocyte folate levels, oral contraceptive use and abnormal cervical cytology. Acta Cytol 1994; 38: 324–30.

    Google Scholar 

  57. Amburgey CF, VanEenwyk J, Davis FG, et al. Undernutrition as a risk factor for cervical intraepithelial neoplasia: a case-control analysis. Nutr Cancer 1993; 20: 51–60.

    Google Scholar 

  58. Brock KE, Gridley G, Morris JS, Willett WC. Serum selenium level in relation to in situ cervical cancer in Australia. JNCI 1991; 83: 292–3.

    Google Scholar 

  59. Brock KE, Hoover RN, Hensley WJ, Plasma chloesterol and in situ cervical cancer: an Australian case-control study (Letter). J Clin Epidemiol 1989; 42: 87–9.

    Google Scholar 

  60. Hillemanns R, Tannous-Khuri L, Koulos JP, Talmage D, Wright TCJr. Localization of cellular retinoid-binding proteins in human cervical intraepithelial neoplasia and invasive carcinoma. Am J Pathol 1992; 141: 973–80.

    Google Scholar 

  61. Sizemore N, Rorke EA. Human papillomavirus 16 immortalization of normal human ectocervical epithelial cells alters retinoic acid regulation of cell growth and epidermal growth factor receptor expression. Cancer Res 1993; 53: 4511–7.

    Google Scholar 

  62. Choo CK, Rorke EA, Eckert RL. Retinoid regulation of cell differentiation in a series of human papillomavirus type 16-immortalized human cervical epithelial cell lines. Carcinogenesis 1995; 16: 375–81.

    Google Scholar 

  63. Steinmetz KA, Potter JD. Vegetables, fruit and cancer. II. Mechanisms. Cancer Causes Control 1991; 2: 427–42.

    Google Scholar 

  64. Di Mascio P, Murphy ME, Sies H. Antioxidant defense systems: the role of carotenoids, tocopherols and thiols. Am J Clin Nutr 1991; 53: 195S-200S.

    Google Scholar 

  65. Henson DE, Block G, Levine M: Ascorbic acid: biologic functions and relation to cancer. JNCI 1991; 83: 547–50.

    Google Scholar 

  66. Ascorbic acid: biologic functions and relation to cancer. Proceedings of a conference held at the National Institutes of Health, Bethesda, Md, September 10–12, 1990. Am J Clin Nutr 1991; 54(6 Suppl): 1113S–327S.

  67. Herbert V, Das KC. Folic acid and vitamin B12. In: Shils ME, Olson JA, Shike M, eds. Modern Nutrition in Health and Disease. 8th Edition. Phildelphia, PA (USA): Lea & Febiger, 1994: 402–25.

    Google Scholar 

  68. Krumdieck CL. Role of folate deficiency in carcinogenesis. In: Butterworth CE, Hutchinson ML, eds. Nutrition Factors in the Induction and Maintenance of Malignancy. New York, NY (USA): Academic Press, 1983: 225–45.

    Google Scholar 

  69. Eto I, Krumdeick CL. Role of vitamin B12 and folate deficiencies in carcinogenesis. Adv Exptl Med Biol 1986; 206: 313–30.

    Google Scholar 

  70. Butterworth CEJr. Effect of folate on cervical cancer. Synergism among risk factors. Ann NY Acad Sci 1992; 669: 293–99.

    Google Scholar 

  71. Tindle RW, Frazer IH. Immune response to human papillomaviruses and the prospects for human papillomavirus-specific immunisation. In: zur Hausen H, ed. Human Pathogenic Papillomaviruses. Hiedelberg, Germany Springer Verlag, 1994: 217–54.

    Google Scholar 

  72. Blumberg JB. Vitamins. In: Forse RA, Bell SJ, Blackburn GL, Kabbash LG, eds. Diet, Nutrition and Immunity. Boca Raton, FL (USA): CRC Press, 1994: 237–46.

    Google Scholar 

  73. Frei B, Stocker R, Ames B. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci 1988; 85: 9748–52.

    Google Scholar 

  74. Bendich A. Carotenoids and immunity. Clin Appl Nutr 1991; 1: 45–51.

    Google Scholar 

  75. Randall E, Marshall J, Graham S, Brasure J. Frequency of food use data and the multidimensionality of diet. J Am Diet Assoc 1989; 89: 1070–5.

    Google Scholar 

  76. Patterson RW, Haines PS, Popkin BM. Diet quality index: capturing a multidimensional behaviour. J Am Diet Assoc 1994; 94: 57–64.

    Google Scholar 

  77. Wacholder S. When measurement errors correlate with truth: surprising effects of nondifferential misclassification. Epidemiology 1995; 6: 157–61.

    Google Scholar 

  78. Basu J, Mikhail MS, Goldberg GL, Palan PR, Romney SL. Measurement of ascorbic acid and glutathione in exfoliated cervicovaginal epithelial cells of smokers and women with cervical dysplasias. Gynecol Obstet Invest 1990; 30: 48–51.

    Google Scholar 

  79. Basu J, Mikhail MS, Payraudeau PH, Palan PR, Romney SL. Smoking and the antioxidant ascorbic acid: plasma, leukocyte, and cervicovaginal cell concentrations in normal healthy women. Am J Obstet Gynecol 1990; 163: 1948–52.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Potischman, N., Brinton, L.A. Nutrition and cervical neoplasia. Cancer Causes Control 7, 113–126 (1996). https://doi.org/10.1007/BF00115643

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00115643

Key words

Navigation